title: [Good experiences with an implantable automatic defibrillator with transvenous electrodes for patients with life-threatening arrhythmias].
abstract: OBJECTIVE
  To describe the results of treatment of patients with a life-threatening arrhythmia by implantation of an second generation implantable cardioverter defibrillator with transvenous electrodes.
  
  
  METHODS
  Descriptive.
  
  
  METHODS
  St.-Antonius Hospital, Nieuwegein, the Netherlands.
  
  
  METHODS
  In the period October 1991-February 1996 the ICD with transvenous electrodes was implanted in 44 patients. After a year the quality of life was assessed by written questionnaire.
  
  
  RESULTS
  The in-hospital mortality was 1/44 (2%), without peroperative death. During follow-up 4 patients died: 3 due to congestive heart failure and 1 due to sudden cardiac death. Within one year 50% of the patients had a therapeutical ICD discharge. In 30/44 (68%) patients antiarrhythmic drugs were prescribed to reduce the number of ICD discharges or because they were suffering from paroxysmal atrial fibrillation with high heart rates, which could result in an inappropriate ICD discharge. Quality of life analysis showed a good acceptance of the ICD, although 86% of the patients considered it a very serious limitation that they were not allowed to drive a motor vehicle anymore.
  
  
  CONCLUSIONS
  The ICD constitutes a major step forward in the treatment of life-threatening ventricular arrhythmias because the implantation is easier and follow-up shows adequate antiarrhythmic effects and survival.
authors.affiliation: St.-Antonius Ziekenhuis, afd. Cardiologie, Nieuwegein.
authors.forename: E R
authors.initials: ER
authors.lastname: Jessurun
authors.forename: B A
authors.initials: BA
authors.lastname: Hutten
authors.forename: N M
authors.initials: NM
authors.lastname: van Hemel
authors.forename: J C
authors.initials: JC
authors.lastname: Kelder
authors.forename: J J
authors.initials: JJ
authors.lastname: Defauw
authors.forename: H
authors.initials: H
authors.lastname: Bakema
mesh_terms: D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000523:psychology; D004567:Electrodes, Implanted; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life
chemical_list: D000889:Anti-Arrhythmia Agents